Clinical Trials in Phoenix, AZ

Browse 244 Clinical Trials Phoenix Across 1069 Cities
105 Phase 3 Trial · 9006 Clinical Trials Phoenix Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Clinical Trials in Phoenix, AZ

Reviewed by Michael Gill, B. Sc.

Image of Arizona State University Downtown Campus in Phoenix, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Medtronic Evolut PRO+ TAVR System And Guideline-directed Management And Therapy (GDMT)for Constriction, Pathologic

This trial is testing whether the Medtronic TAVR System is safe and effective for patients with moderate, symptomatic aortic stenosis.

Recruiting

Has No Placebo

London Health Sciences Centre - University Campus (+10 Sites)Paul Sorajja, MDMedtronic Cardiovascular

Image of Neurology Associates of Ormond Beach in Ormond Beach, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

IMU-838 Tabletsfor Multiple Sclerosis

This trial is testing a new drug for people with relapsing MS. It is comparing the new drug to a placebo to see if it is better at reducing MS relapses.

Phase 3

Recruiting

1 Prior Treatment

Neurology Associates of Ormond Beach (+5 Sites)R. F., MDImmunic AG

Image of Bausch Site 001 in Palmetto Bay, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Rifaximin SSDfor Hepatic Coma

This trial is testing whether a drug can help prevent hepatic encephalopathy, a complication of liver cirrhosis, in people who have not had it before.

Phase 3

Recruiting

FDA Approved Drug

Bausch Site 001 (+90 Sites)John LaheyBausch Health Americas, Inc.

Image of Regeneron Research Site in Naples, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Pozelimabfor Myasthenia Gravis, Generalized

This trial is testing a combination of two drugs, pozelimab and cemdisiran, to see if it improves daily functioning in people with myasthenia gravis. The secondary objectives are to see if the combination improves symptoms of myasthenia gravis, muscle strength, quality of life, and more. The trial will also assess the safety and side effects of the combination.

Phase 3

Recruiting

Drug

Regeneron Research Site (+18 Sites)Clinical Trial ManagementRegeneron Pharmaceuticals

Image of Digestive Health Specialists of the Southeast in Dothan, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Efavaleukin Alfafor Ulcer

This trial is looking at whether or not a new drug, efavaleukin alfa, can help people with UC achieve clinical remission. Participants will be randomly assigned to receive either the drug or a placebo, and the effects will be monitored over the course of 12 weeks. There is also the option to enter an exploratory long-term treatment period for up to 52 weeks total.

Phase 2

Recruiting

1 Prior Treatment

Digestive Health Specialists of the Southeast (+21 Sites)MDAmgen

Image of Research Site in Orange, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Enfortumab Vedotinfor Malignant Neoplasms

This trial is designed to study the efficacy and safety of Durvalumab in combination with Tremelimumab and Enfortumab Vedotin or Durvalumab in combination with Enfortumab Vedotin compared to SOC in patients ineligible for Cisplatin or who refuse Cisplatin undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer.

Phase 3

Recruiting

FDA Approved Drug

Research Site (+15 Sites)AstraZeneca

Image of Astera Cancer Care in East Brunswick, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Magrolimabfor Breast Cancer

This trial is testing the safety and effectiveness of two different combinations of drugs for people with triple-negative breast cancer that has spread.

Phase 2

Recruiting

FDA Approved Drug

Astera Cancer Care (+16 Sites)Gilead Study DirectorGilead Sciences

Image of University of South Alabama Children's and Women's Hospital in Mobile, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Inclacumabfor Anemia, Sickle Cell

This trial will study whether inclacumab can prevent another vaso-occlusive crisis (VOC) in people with sickle cell disease (SCD), by seeing if it is more effective than placebo.

Phase 3

Recruiting

Online Trial

University of South Alabama Children's and Women's Hospital (+13 Sites)Global Blood Therapeutics

Image of Phoenix location in Phoenix, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

RGX-314for Wet Macular Degeneration

This study is evaluating whether a single injection of a gene therapy vector may help improve vision in individuals with wet age-related macular degeneration.

Phase 2

Recruiting

Has No Placebo

Phoenix location (+25 Sites)Regenxbio Inc.

Image of Pulmonary Associates, PA in Phoenix, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Sotaterceptfor PAH

This trial is testing a drug to see if it's safe and effective for treating Pulmonary Arterial Hypertension.

Phase 3

Recruiting

Has No Placebo

Pulmonary Associates, PA (+21 Sites)Jonathan Lu, MD, PhDAcceleron Pharma Inc.

Image of US Oncology in Phoenix, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Alpelisibfor Ovarian Cancer

This trial is testing a new cancer treatment combination to see if it is more effective and has fewer side effects than current chemotherapy options for women with ovarian cancer who have not responded to other treatments.

Phase 3

Recruiting

FDA Approved Drug

US Oncology (+26 Sites)Novartis Pharmaceuticals

Image of Achieve Clinical Research (dba Accel Research Sites (Neurology and Neurodiagnostics of Alabama) in Birmingham, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

BHV3000 (active Drug)for Sick Headache

This trial will test if a new drug, BHV-3000, is safe and effective in treating migraines in children and adolescents.

Phase 3

Recruiting

FDA Approved Drug

Achieve Clinical Research (dba Accel Research Sites (Neurology and Neurodiagnostics of Alabama) (+79 Sites)Biohaven Pharmaceutical Holding Company Ltd.

Image of Arizona Institute of Urology in Tucson, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Standard Ureteroscopy (Basketing)for Urolithiasis

This trial will compare the two most common treatments for kidney stones.

Recruiting

Has No Placebo

Arizona Institute of Urology (+9 Sites)Calyxo, Inc.

Image of Mayo Clinic Arizona in Phoenix, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Vancomycinfor Cholangitis, Sclerosing

This trial is testing whether vancomycin is a safe and effective treatment for primary sclerosing cholangitis.

Phase 2 & 3

Recruiting

FDA Approved Drug

Mayo Clinic Arizona (+2 Sites)Elizabeth Carey, MD

Image of ATP Clinical Research, Inc. in Costa Mesa, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Pimavanserinfor Neuropsychiatric Symptoms Related to Neurodegenerative Disease

This trial will study the safety and tolerability of the drug pimavanserin when taken by adults and elderly patients with neuropsychiatric symptoms related to neurodegenerative diseases, over the course of 52 weeks.

Phase 3

Waitlist Available

FDA Approved Drug

ATP Clinical Research, Inc. (+5 Sites)ACADIA Pharmaceuticals Inc.

Image of University of Alabama in Birmingham, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Photonfor Breast Cancer

This trial is testing whether proton therapy or photon therapy is better for treating breast cancer. It will follow patients for side effects, quality of life, and cancer control.

Recruiting

Has No Placebo

University of Alabama (+26 Sites)Justin Bekelman, MD

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Effectiveness

Safety

Crizotinibfor ALK Gene Rearrangement

This trial studies crizotinib for patients with stage IB-IIIA NSCLC who have had surgery and have an ALK fusion mutation. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working.

Phase 3

Recruiting

FDA Approved Drug

Anchorage Associates in Radiation Medicine (+99 Sites)David Gerber

25 Clinical Trials Phoenix Near Me

Top Cities for Clinical Trials Phoenix

Phoenix

266Active Trials

Phoenix Childrens HospitalTop Active Site

Los Angeles

156Active Trials

Cedars Sinai Medical CenterTop Active Site

Clinical Trials in Phoenix, AZ

Browse 244 Clinical Trials Phoenix Across 1069 Cities105 Phase 3 Trial · 9006 Clinical Trials Phoenix Clinics

Heart Rate Variability Biofeedbackfor Caregiver Burden

Imlunestrantfor Breast Cancer

Bright Light Therapy Groupfor Sleep Disturbance

Tadefgrobep Alfafor Oppenheim Disease

Ocrelizumabfor Multiple Sclerosis

ALXN2050for Myasthenia Gravis, Generalized

Encorafenib & Binimetinib Treatmentfor Tumors, Solid

OptiPulse™for Diabetic Foot Ulcers (DFUs)

Medtronic Evolut PRO+ TAVR System And Guideline-directed Management And Therapy (GDMT)for Constriction, Pathologic

IMU-838 Tabletsfor Multiple Sclerosis

Rifaximin SSDfor Hepatic Coma

Pozelimabfor Myasthenia Gravis, Generalized

Efavaleukin Alfafor Ulcer

Enfortumab Vedotinfor Malignant Neoplasms

Magrolimabfor Breast Cancer

Inclacumabfor Anemia, Sickle Cell

RGX-314for Wet Macular Degeneration

Sotaterceptfor PAH

Alpelisibfor Ovarian Cancer

BHV3000 (active Drug)for Sick Headache

Standard Ureteroscopy (Basketing)for Urolithiasis

Vancomycinfor Cholangitis, Sclerosing

Pimavanserinfor Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Photonfor Breast Cancer

Crizotinibfor ALK Gene Rearrangement

Browse 244 Clinical Trials Phoenix Across 1069 Cities
105 Phase 3 Trial · 9006 Clinical Trials Phoenix Clinics